DocGo (NASDAQ:DCGO) Releases Earnings Results, Misses Estimates By $1.28 EPS

DocGo (NASDAQ:DCGO) released its quarterly earnings results on Monday. The company reported ($1.37) EPS for the quarter, missing the consensus estimate of ($0.09) by ($1.28), FiscalAI reports. DocGo had a negative return on equity of 9.11% and a negative net margin of 14.02%.The company had revenue of $74.94 million for the quarter, compared to analysts’ expectations of $70.36 million.

DocGo Stock Performance

DCGO traded down $0.01 during trading on Monday, reaching $0.65. The company’s stock had a trading volume of 2,150,583 shares, compared to its average volume of 749,155. The company’s fifty day moving average price is $0.78 and its 200-day moving average price is $1.04. DocGo has a 52-week low of $0.60 and a 52-week high of $2.89. The company has a market capitalization of $63.33 million, a price-to-earnings ratio of -1.25 and a beta of 0.95.

Institutional Trading of DocGo

Hedge funds have recently modified their holdings of the business. Neuberger Berman Group LLC purchased a new stake in shares of DocGo in the fourth quarter valued at approximately $29,000. Cerity Partners LLC purchased a new position in DocGo in the second quarter worth $37,000. Public Employees Retirement System of Ohio acquired a new stake in DocGo in the fourth quarter valued at $40,000. Engineers Gate Manager LP acquired a new stake in DocGo in the second quarter valued at $52,000. Finally, Jain Global LLC purchased a new stake in shares of DocGo during the 4th quarter worth $70,000. 56.44% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of DocGo in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $2.25.

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.